We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cerenis Reports Positive Results for Phase 1 Study of CER-001 for the Treatment of Cardiovascular Disease

News   May 18, 2010

 
Cerenis Reports Positive Results for Phase 1 Study of CER-001 for the Treatment of Cardiovascular Disease
 
 
 

RELATED ARTICLES

Common Disease Mechanism for ALS and Frontotemporal Dementia

News

Findings suggest mutations leading to accumulation of RNA-binding proteins to blame for disease, and could offer route for early diagnosis

READ MORE

Liquid Biopsy Predicts Lymphoma Therapy Success Within Days

News

Being able to identify people who are responding well to therapy may spare them from unnecessary additional treatments.

READ MORE

Progress Toward Personalized Medicine: Microfluidic Chip for Analysis of Single Cells

News

New microfluidics-based chip allows for the manipulation and nucleic-acid analysis of individual cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE